BioSpace News Archive

Business

Illinois Biotechnology Innovation Organization Announces Astellas’ Walt Johnston as New Chairman

Astellas’ Walt Johnston has been elected as chairman of the iBIO and iBIO Institute Boards of Directors. He succeeds Timothy P Walbert, Horizon Pharma, who served as chairman for the past two years and who will continue to serve on the Board and Executive Committee as Immediate Past Chairman.

December 7, 2017

·

2 min read

Drug Development

CRISPR Therapeutics Submits First Clinical Trial Application for a CRISPR Gene-Edited Therapy, CTX001 in β-thalassemia

CTX001 is an investigational CRISPR gene-edited autologous hematopoietic stem cell therapy for patients suffering from β-thalassemia and sickle cell disease.

December 7, 2017

·

5 min read

Drug Development

Pluristem to Present Data on PLX-R18 in Treatment of Acute Radiation Syndrome at American Society of Hematology’s Annual Meeting

The results of the study will be presented during Program Session 506: Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells.

December 7, 2017

·

5 min read

Orthocell Commences Treatment of its 1,000th Patient

This marks a significant milestone in the Company’s history as it continues to clinically validate its market leading regenerative medicine technologies and drive entry into the US, the world’s largest healthcare market.

December 7, 2017

·

4 min read

SuperSonic Imagine Installs Six Aixplorer Ultimate Ultrasound Systems at ‘Occitanie-Garonne’ Medical Imaging Group

The radiology sites specialize, among other things, in detecting and characterising musculotendinous and mammary lesions, and diagnosing abdominal diseases with 14 radiologists who conduct all of the diagnostic and therapeutic exams.

December 7, 2017

·

5 min read

Drug Development

Novo Nordisk’s Tresiba Reduces Hypoglycaemia Regardless of Blood Sugar Level

These new post-hoc analyses from the SWITCH 1 and 2 trials were presented at the International Diabetes Federation Annual Congress in Abu Dhabi today.

December 7, 2017

·

5 min read

Business

Median Technologies Inks a Research Collaboration Agreement for Lung Cancer Screening Programs With Xingtai People’s Hospital, Xingtai City, China

Within the frame of the agreement, Median’s MediScan® image analysis technology will be used to conduct lung cancer screening programs organized under the aegis of Xingtai People’s Hospital in Xingtai City.

December 7, 2017

·

3 min read

Drug Development

Long-Term Efficacy Data From the Phase III GeparSepto Study in High Risk Early Breast Cancer Patients Treated With ABRAXANE Vs. Solvent-Based Paclitaxel to Be Reported

The results from the 1,206 patient study found that ABRAXANE demonstrated a significantly higher disease-free survival rate, a secondary efficacy endpoint, in high risk early breast cancer patients when compared to conventional solvent-based paclitaxel.

December 7, 2017

·

14 min read

Business

Generex Announces Collaboration With Shenzhen BioScien Pharmaceuticals to Develop and Commercialize the AE37 Immunotherapeutic Vaccine for the Treatment of Prostate Cancer in China

Shenzhen BioScien will pay Generex a non-refundable, up-front license fee of $700,000 USD.

December 7, 2017

·

4 min read

Expert Review Panel for Diagnostics Approves Atomo HIV Self Test for Procurement by Unitaid and the Global Fund

Following on from its recent CE Mark approval, which enables Atomo to market the product in Europe, the ERP-D approval will facilitate further expansion and commercial roll-out of the product in LMICs.

December 7, 2017

·

2 min read